93 related articles for article (PubMed ID: 36646707)
1. PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathway.
Zhang R; Dong M; Tu J; Li F; Deng Q; Xu J; He X; Ding J; Xia J; Sheng D; Chang Z; Ma W; Dong H; Zhang Y; Zhang L; Zhang L; Liu S
Signal Transduct Target Ther; 2023 Mar; 8(1):97. PubMed ID: 36859354
[TBL] [Abstract][Full Text] [Related]
2. Unlocking the secrets of cancer stem cells: Immune checkpoint inhibitors face their formidable foes.
Roarty K
Cell Stem Cell; 2023 Jun; 30(6):743-744. PubMed ID: 37267909
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of cancer stem cell: regulatory factors elucidation and cancer treatment strategies.
Zhang Z; Zhang Y
J Exp Clin Cancer Res; 2024 Apr; 43(1):99. PubMed ID: 38561775
[TBL] [Abstract][Full Text] [Related]
4. The Burgeoning Significance of Liquid-Liquid Phase Separation in the Pathogenesis and Therapeutics of Cancers.
Xu WX; Qu Q; Zhuang HH; Teng XQ; Wei YW; Luo J; Dai YH; Qu J
Int J Biol Sci; 2024; 20(5):1652-1668. PubMed ID: 38481812
[TBL] [Abstract][Full Text] [Related]
5. Improving hematopoietic differentiation from human induced pluripotent stem cells by the modulation of Hippo signaling with a diarylheptanoid derivative.
Thongsa-Ad U; Wongpan A; Wongkummool W; Chaiwijit P; Uppakara K; Chaiyakitpattana G; Singpant P; Tong-Ngam P; Chukhan A; Pabuprappap W; Wongniam S; Suksamrarn A; Hongeng S; Anurathapan U; Kulkeaw K; Tubsuwan A; Bhukhai K
Stem Cell Res Ther; 2024 Mar; 15(1):60. PubMed ID: 38433217
[TBL] [Abstract][Full Text] [Related]
6. Interconversion of Cancer Cells and Induced Pluripotent Stem Cells.
Sarker DB; Xue Y; Mahmud F; Jocelyn JA; Sang QA
Cells; 2024 Jan; 13(2):. PubMed ID: 38247819
[TBL] [Abstract][Full Text] [Related]
7. Linking cell mechanical memory and cancer metastasis.
Cambria E; Coughlin MF; Floryan MA; Offeddu GS; Shelton SE; Kamm RD
Nat Rev Cancer; 2024 Mar; 24(3):216-228. PubMed ID: 38238471
[TBL] [Abstract][Full Text] [Related]
8. Molecular, Cellular, and Technical Aspects of Breast Cancer Cell Lines as a Foundational Tool in Cancer Research.
Witt BL; Tollefsbol TO
Life (Basel); 2023 Dec; 13(12):. PubMed ID: 38137912
[TBL] [Abstract][Full Text] [Related]
9. Mechanobiology in oncology: basic concepts and clinical prospects.
Chen MB; Javanmardi Y; Shahreza S; Serwinski B; Aref A; Djordjevic B; Moeendarbary E
Front Cell Dev Biol; 2023; 11():1239749. PubMed ID: 38020912
[TBL] [Abstract][Full Text] [Related]
10. The role of matrix stiffness in breast cancer progression: a review.
Xu R; Yin P; Wei J; Ding Q
Front Oncol; 2023; 13():1284926. PubMed ID: 37916166
[TBL] [Abstract][Full Text] [Related]
11. Cancer Stem Cells and the Tumor Microenvironment in Tumor Drug Resistance.
Gao Q; Zhan Y; Sun L; Zhu W
Stem Cell Rev Rep; 2023 Oct; 19(7):2141-2154. PubMed ID: 37477773
[TBL] [Abstract][Full Text] [Related]
12. Tumor matrix stiffness provides fertile soil for cancer stem cells.
Safaei S; Sajed R; Shariftabrizi A; Dorafshan S; Saeednejad Zanjani L; Dehghan Manshadi M; Madjd Z; Ghods R
Cancer Cell Int; 2023 Jul; 23(1):143. PubMed ID: 37468874
[TBL] [Abstract][Full Text] [Related]
13. The global landscape and research trend of phase separation in cancer: a bibliometric analysis and visualization.
Li M; Zhang Y; Zhao J; Wang D
Front Oncol; 2023; 13():1170157. PubMed ID: 37333812
[TBL] [Abstract][Full Text] [Related]
14. Getting physical: Material mechanics is an intrinsic cell cue.
Atcha H; Choi YS; Chaudhuri O; Engler AJ
Cell Stem Cell; 2023 Jun; 30(6):750-765. PubMed ID: 37267912
[TBL] [Abstract][Full Text] [Related]
15. Niche stiffness sustains cancer stemness via TAZ and NANOG phase separation.
Liu X; Ye Y; Zhu L; Xiao X; Zhou B; Gu Y; Si H; Liang H; Liu M; Li J; Jiang Q; Li J; Yu S; Ma R; Su S; Liao JY; Zhao Q
Nat Commun; 2023 Jan; 14(1):238. PubMed ID: 36646707
[TBL] [Abstract][Full Text] [Related]
16. RNA Polymerase II-Associated Factor 1 Regulates Stem Cell Features of Pancreatic Cancer Cells, Independently of the PAF1 Complex, via Interactions With PHF5A and DDX3.
Karmakar S; Rauth S; Nallasamy P; Perumal N; Nimmakayala RK; Leon F; Gupta R; Barkeer S; Venkata RC; Raman V; Rachagani S; Ponnusamy MP; Batra SK
Gastroenterology; 2020 Nov; 159(5):1898-1915.e6. PubMed ID: 32781084
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of TAZ decrease the cancer stem properties of ESCC cell line YM-1 by modulation of Nanog, OCT-4 and SOX2.
Khosravi A; Jafari SM; Asadi J
Gene; 2021 Feb; 769():145207. PubMed ID: 33031893
[TBL] [Abstract][Full Text] [Related]
18. Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells.
Huang ZJ; You J; Luo WY; Chen BS; Feng QZ; Wu BL; Jiang L; Luo Q
Mol Med Rep; 2015 Mar; 11(3):1647-54. PubMed ID: 25405855
[TBL] [Abstract][Full Text] [Related]
19. The oncogenic potential of NANOG: An important cancer induction mediator.
Najafzadeh B; Asadzadeh Z; Motafakker Azad R; Mokhtarzadeh A; Baghbanzadeh A; Alemohammad H; Abdoli Shadbad M; Vasefifar P; Najafi S; Baradaran B
J Cell Physiol; 2021 Apr; 236(4):2443-2458. PubMed ID: 32960465
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
